Patent ID: 11952634
Assignee: MEDIVATION PROSTATE THERAPEUTICS LLC
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 17:
18. A method of treating triple negative breast cancer in a subject in need of such treatment comprising:
(a) providing a biological sample from the subject;
(b) assaying the biological sample to determine whether the biological sample is classified as a basal-like subtype or another subtype from the expression of the set of intrinsic genes listed in Table 1 using a PAM50 classifier and detecting the set of intrinsic genes by RNA sequencing; and
(c) if the biological sample is classified as other than a basal-like subtype, administering a breast cancer treatment to the subject comprising an androgen receptor inhibitor, thereby treating the breast cancer in the subject.